Regional research offices
Chuck Howard - Patient story
Julie Randall - Patient story
Tara Foote - Provider story
If you have questions about clinical trials or want help finding the right one for you, contact our:
Patient Engagement Center Phone: 844-552-2734
This is a preliminary search of all open and enrolling clinical trials across our regions and affiliate organizations that have sponsors' permission to publish to this website.
Please use the filtering options in the right column to refine your search. Otherwise ALL open and enrolling clinical trials will display below.
A study to evaluate the safety of Nivolumab administered in combination with Ipilimumab in patients with advanced cancers. The initial cohort will...
To Determine if SAbR improves survival over SR in High Risk Operable Stage I NSCLC. Stereotactic Ablative Radiotherapy has been shown in single...
1. Cohort 1(combination of niraparib and pembrolizumab): patients must have tumors with high PD-L1 expression (TPS ≥ 50%) per local assessment,...
This study will look at how effective the study drug (tepotinib) is at stopping the growth and spread of lung cancer that carries a specific...
General Inclusion Criteria (all dose escalation and expansion cohorts):• Have histologically or cytologically confirmed locally advanced (and not a...